Garrett Winslow
General Counsel
Damora Therapeutics, Inc. (DMRA)Equibles does not estimate personal net worth.
Get an email with a short summary when Damora Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DMRA alertsAbout Garrett Winslow
Garrett Winslow is recorded as General Counsel at Damora Therapeutics, Inc. (DMRA). The newest filing on record that lists Garrett Winslow as General Counsel at Damora Therapeutics, Inc. (DMRA) is dated April 29, 2026. The proxy statement of Damora Therapeutics, Inc. reports total compensation of $854,755 for Garrett Winslow in fiscal 2025, including a base salary of $400,400. Disclosed compensation is on record for 3 fiscal years. Damora Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Damora Therapeutics, Inc. includes Jennifer Jarrett (CEO and Board Member), Sherwin Sattarzadeh (CEO and COO), Peter Harwin (Chairman and Board Member) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 29, 2026
Company network
Leadership on record at Damora Therapeutics, Inc.
- Jennifer Jarrett CEO, Board Member
- Sherwin Sattarzadeh CEO, COO
- Peter Harwin Chairman, Board Member
- Lori Firmani CFO
- Brian Burkavage Chief Accounting Officer
- Amy Wechsler Board Member
- Anne Prener Board Member
- Cameron Turtle Board Member
- Chris Cain Board Member
- Chris Cain, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Damora Therapeutics, Inc. (DMRA) | General Counsel | $400,400 | $854,755 |
| 2024 | Damora Therapeutics, Inc. (DMRA) | General Counsel | $400,400 | $897,368 |
| 2023 | Damora Therapeutics, Inc. (DMRA) | General Counsel | $385,000 | $554,388 |
Recent activity
No call appearances or filed executive changes recorded yet.